Inquirer Business on MSN
Nuclear energy implementing rules out in early ’26
The implementing rules and regulations (IRR) for PhilATOM, the country’s newly established atomic energy regulator, could be ...
The company received tentative approval from USFDA for diabetes drug, which will be produce in Ahmedabad facility.
Zydus Lifesciences on Thursday said it has received approval from the US health regulator to market a generic diabetes drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback